Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 May;8(2):183-5.
doi: 10.1007/BF00177255.

Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer

D S Ettinger  1 , D M Finkelstein, M D Abeloff, Y C Chang, T J Smith, M M Oken, J C Ruckdeschel
Affiliations
Clinical Trial

Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer

D S Ettinger et al. Invest New Drugs. 1990 May.

Abstract

Fifty-four evaluable patients with SCLC previously treated with chemotherapy received either N-methylformamide or spirogermanium. There was one partial response to N-methylformamide. The median survival times for patients treated with N-MF and spirogermanium were 11.7 and 12.6 weeks respectively. Five patients treated with N-MF experienced severe toxicity while four patients treated with spirogermanium experienced severe and life-threatening toxicity.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1975 Mar;72(3):1003-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1978 May;75(5):2458-62 - PubMed
    1. Am J Clin Oncol. 1982 Dec;5(6):649-55 - PubMed

Publication types

LinkOut - more resources